Related Experiment Video
Updated: Jun 13, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Infiltrative cardiovascular diseases: cardiomyopathies that look alike
James B Seward1, Grace Casaclang-Verzosa
1Divisions of Cardiovascular Diseases, General Internal Medicine, and Pediatric Cardiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. seward@mayo.edu
Insights
Infiltrative cardiomyopathies stiffen heart walls, mimicking other heart conditions. Diagnosis often requires tissue or blood tests to confirm the specific infiltrative cardiomyopathy and guide treatment.
Area of Science:
- Cardiology
- Pathology
Background:
- Infiltrative cardiomyopathies involve abnormal substance deposition, leading to ventricular rigidity and impaired filling.
- These conditions can present with increased wall thickness or chamber enlargement, mimicking other cardiac diseases like hypertrophic or ischemic cardiomyopathy.
- While low-voltage QRS complexes suggest infiltrative cardiomyopathy (e.g., cardiac amyloidosis), this finding is not universal.
Purpose of the Study:
- To differentiate infiltrative cardiomyopathies from other cardiac conditions based on clinical presentation and imaging features.
- To highlight the diagnostic challenges posed by the varied presentations of infiltrative cardiomyopathies.
- To emphasize the necessity of definitive diagnostic methods for appropriate patient management.
Main Methods:
- Review of clinical presentations of infiltrative cardiomyopathies.
- Analysis of functional and morphologic cardiac features.
- Discussion of diagnostic criteria and confirmatory tests.
Main Results:
- Infiltrative cardiomyopathies can mimic hypertrophic cardiomyopathy (thickening) or ischemic cardiomyopathy (dilated chambers, wall motion abnormalities).
- Low-voltage QRS on electrocardiogram is suggestive but not consistently present in all infiltrative cardiomyopathies.
- Clinical and imaging findings provide initial diagnostic clues, but definitive diagnosis often relies on tissue or serologic evaluation.
Conclusions:
- Accurate diagnosis of infiltrative cardiomyopathies relies on integrating clinical, imaging, and electrocardiographic data.
- Distinguishing infiltrative cardiomyopathies from other heart diseases is crucial for effective therapeutic strategies.
- Tissue or serologic confirmation is frequently required to establish a definitive diagnosis and initiate appropriate treatment for infiltrative cardiomyopathies.
Abstract:
Infiltrative cardiomyopathies are characterized by the deposition of abnormal substances that cause the ventricular walls to become progressively rigid, thereby impeding ventricular filling. Some infiltrative cardiac diseases increase ventricular wall thickness, while others cause chamber enlargement with secondary wall thinning. Increased wall thickness, small ventricular volume, and occasional dynamic left ventricular outflow obstruction (e.g., amyloidosis) can outwardly appear similar to conditions with true myocyte hypertrophy (e.g., hypertrophic cardiomyopathy, hypertensive heart disease). Likewise, infiltrative disease that presents with a dilated left ventricle with global or regional wall motion abnormalities and aneurysm formation (e.g., sarcoidosis) may mimic ischemic cardiomyopathy. Low-voltage QRS complex was the sine qua non of infiltrative cardiomyopathy (i.e., cardiac amyloid). However, low-voltage QRS complex is not a uniform finding with the infiltrative cardiomyopathies. The clinical presentation, along with functional and morphologic features, often provides enough insight to establish a working diagnosis. In most circumstances, however, tissue or serologic evaluation is needed to validate or clarify the cardiac diagnosis and institute appropriate therapy.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests

